Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 48 citing articles:

Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer
Eva Kúdelová, Marek Smolár, Veronika Holubeková, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14937-14937
Open Access | Times Cited: 62
Overcoming anti-PD-1/PD-L1 immune checkpoint blockade resistance: the role of macrophage, neutrophils and mast cells in the tumor microenvironment
Louis Boafo Kwantwi
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3077-3091
Closed Access | Times Cited: 20
Aberrant promoter hypermethylation of miR-335 and miR-145 is involved in breast cancer PD-L1 overexpression
Sara Hajibabaei, Fattah Sotoodehnejadnematalahi, Nahid Nafissi, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities
Wenyu Cai, Xiaoli Cai, Yi-ran Fei, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Roles and mechanisms of miR-195–5p in human solid cancers
Qi Xu, Jia-lin Xu, Wenquan Chen, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112885-112885
Open Access | Times Cited: 23
New Achievements for the Treatment of Triple-Negative Breast Cancer
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, et al.
Applied Sciences (2022) Vol. 12, Iss. 11, pp. 5554-5554
Open Access | Times Cited: 23
Decoding the Intricate Landscape of Pancreatic Cancer: Insights into Tumor Biology, Microenvironment, and Therapeutic Interventions
Antonella Argentiero, Alessandro Andriano, Ingrid Catalina Caradonna, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2438-2438
Open Access | Times Cited: 4
p53 downregulates PD-L1 expression via miR-34a to inhibit the growth of triple-negative breast cancer cells: a potential clinical immunotherapeutic target
Siyu Deng, Mengna Wang, Chenglong Wang, et al.
Molecular Biology Reports (2022) Vol. 50, Iss. 1, pp. 577-587
Closed Access | Times Cited: 20
Local Breast Microbiota: A “New” Player on the Block
M. Vitorino, Diogo Alpuim Costa, Rodrigo Vicente, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3811-3811
Open Access | Times Cited: 18
MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer Treatment
Huiling Zhou, Wentao Jia, Lingeng Lu, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 824-824
Open Access | Times Cited: 10
A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery
Mahdi Abdoli Shadbad, Zahra Asadzadeh, Afshin Derakhshani, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112213-112213
Open Access | Times Cited: 26
Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancer
Md Shahin Alam, Adiba Sultana, Guanghui Wang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 16
hsa-miR-34a-5p enhances temozolomide anti-tumoral effects on glioblastoma: in-silico and in-vitro study.
Mahdi Abdoli Shadbad, Amir Baghbanzadeh, Behzad Baradaran
PubMed (2024) Vol. 23, pp. 384-400
Closed Access | Times Cited: 2
A Systematic Review and Meta-Analysis on the Significance of TIGIT in Solid Cancers: Dual TIGIT/PD-1 Blockade to Overcome Immune-Resistance in Solid Cancers
Negar Hosseinkhani, Mahdi Abdoli Shadbad, Mohammad Asghari Jafarabadi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10389-10389
Open Access | Times Cited: 19
A Systematic Review of the Tumor-Infiltrating CD8+ T-Cells/PD-L1 Axis in High-Grade Glial Tumors: Toward Personalized Immuno-Oncology
Mahdi Abdoli Shadbad, Zahra Asadzadeh, Negar Hosseinkhani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 18
A Systematic Review on PD-1 Blockade and PD-1 Gene-Editing of CAR-T Cells for Glioma Therapy: From Deciphering to Personalized Medicine
Mahdi Abdoli Shadbad, Nima Hemmat, Vahid Khaze, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 13
Over-Expression of GUSB Leads to Primary Resistance of Anti-PD1 Therapy in Hepatocellular Carcinoma
Xiangyi Kong, Zhiying Zheng, Guoxin Song, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
A scoping review on the significance of programmed death-ligand 1-inhibiting microRNAs in non-small cell lung treatment: A single-cell RNA sequencing-based study
Mahdi Abdoli Shadbad, Farid Ghorbaninezhad, Hamidreza Hassanian, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 12
Dual silencing of tumor-intrinsic VISTA and CTLA-4 stimulates T-cell mediated immune responses and inhibits MCF7 breast cancer development
Negar Hosseinkhani, Nima Hemmat, Elham Baghbani, et al.
Gene (2023) Vol. 896, pp. 148043-148043
Closed Access | Times Cited: 7
The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer
Ф. М. Кипкеева, Tatyana Muzaffarova, А. А. Коротаева, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9324-9324
Open Access | Times Cited: 11
HSV1 microRNAs in glioblastoma development: an in silico study
Mahdi Abdoli Shadbad, Nima Hemmat, Mahla Abdoli Shadbad, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Hormone, Targeted, and Combinational Therapies for Breast Cancers: From Humans to Dogs
Chiao‐Hsu Ke, Chao‐Nan Lin, Chen‐Si Lin
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 732-732
Open Access | Times Cited: 1
Histologic Characterization of Tumor-Adjacent Mammary Adipose Tissue in Normal-Weight and Overweight/ObesePatients with Triple-Negative Breast Cancer
M. Wolf, Christoph Brochhausen, Vignesh Ramakrishnan, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3515-3515
Open Access | Times Cited: 1
Blood Circulating Non-Coding RNAs for the Clinical Management of Triple-Negative Breast Cancer
Tomasz Powrózek, Michael Ochieng Otieno
Cancers (2022) Vol. 14, Iss. 3, pp. 803-803
Open Access | Times Cited: 8
Efficacy of zinc carnosine in the treatment of colorectal cancer and its potential in combination with immunotherapy in vivo
Weiwei Tang, Hanyuan Liu, Xiao Li, et al.
Aging (2022) Vol. 14, Iss. 21, pp. 8688-8699
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top